1061682-81-2 Usage
Uses
Used in Pharmaceutical Development:
(R)-N,N-diMethylpiperidin-3-aMine hydrochloride is used as an intermediate in the synthesis of various pharmaceutical compounds. Its chiral nature allows for the creation of enantiomer-specific drugs, which can have different biological activities and reduce potential side effects.
Used in Organic Synthesis:
(R)-N,N-diMethylpiperidin-3-aMine hydrochloride serves as a reagent in organic synthesis, facilitating the formation of complex organic molecules. Its unique structure and reactivity make it a valuable building block for the preparation of other chemical compounds.
Used in Research Applications:
In the field of research, (R)-N,N-diMethylpiperidin-3-aMine hydrochloride is utilized for studying the effects of chirality on biological activity and drug interactions. Its use in research helps to advance the understanding of stereochemistry and its implications in drug design and development.
Used in Drug Synthesis Processes:
(R)-N,N-diMethylpiperidin-3-aMine hydrochloride is used as a key component in the synthesis of various drugs, particularly those targeting the central nervous system. Its improved solubility and stability in the hydrochloride salt form make it an ideal candidate for drug development, ensuring the effective delivery of the active pharmaceutical ingredient.
Check Digit Verification of cas no
The CAS Registry Mumber 1061682-81-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,1,6,8 and 2 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1061682-81:
(9*1)+(8*0)+(7*6)+(6*1)+(5*6)+(4*8)+(3*2)+(2*8)+(1*1)=142
142 % 10 = 2
So 1061682-81-2 is a valid CAS Registry Number.
1061682-81-2Relevant academic research and scientific papers
AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS
-
Page/Page column 33-34, (2010/06/16)
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment
